Ricardo Fonseca Oliveira Suruagy Motta

Ricardo Fonseca Oliveira Suruagy Motta

Auto-generated profile, based on publicly available information

Ricardo Fonseca Oliveira Suruagy Motta

Department of Medicine, Cesmac University Center, Maceió, Alagoas, Brazil

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 May 2025 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Closed access
RSRicardo Fonseca Oliveira Suruagy‐Motta
Ricardo Fonseca Oliveira Suruagy‐Motta
LCLucas Silva Cabeça
Lucas Silva Cabeça
ASAnderson Matheus Pereira Da Silva
Anderson Matheus Pereira Da Silva
GNGabriel Rezende Neves
Gabriel Rezende Neves
MCMaria Tereza Camarotti
Maria Tereza Camarotti
MOMarcos Danillo Oliveira
Marcos Danillo Oliveira

10 August 2025 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Closed access
RSRicardo F. O. Suruagy‐Motta
Ricardo F. O. Suruagy‐Motta
CFChristian K. Fukunaga
Christian K. Fukunaga
ESEverton V. B. da Silva
Everton V. B. da Silva
GNGabriel R. Neves
Gabriel R. Neves
KSKarlos D. A. dos Santos
Karlos D. A. dos Santos
GCGuilherme D. de Carvalho
Guilherme D. de Carvalho

15 October 2025 in The American Journal of Cardiology
Verified
Journal Article
Closed access
RSRicardo F.O Suruagy-Motta
Ricardo F.O Suruagy-Motta
LALuiz Guilherme Silva Almeida
Luiz Guilherme Silva Almeida
JTJulia Tirelli-Rocha
Julia Tirelli-Rocha
GNGabriel Rezende Neves
Gabriel Rezende Neves
RFRafael Batista Félix
Rafael Batista Félix
GSGregg W. Stone
Gregg W. Stone

3 February 2026 in Clinical Imaging
Verified
Journal Article
Closed access
VOVictor Arthur Ohannesian
Victor Arthur Ohannesian
DRDiego Rajchenberg
Diego Rajchenberg
IMIsabelle R. Menezes
Isabelle R. Menezes
MHMariana Lee Han
Mariana Lee Han
KPKarina L.A. Pereira
Karina L.A. Pereira
SNSolange Amorim Nogueira
Solange Amorim Nogueira

1 January 2026 in Arquivos Brasileiros de Cardiologia
Verified
Journal Article
Open access
PDF file
MOMarcos Danillo Oliveira
Marcos Danillo Oliveira
RSRicardo Fonseca Oliveira Suruagy-Motta
Ricardo Fonseca Oliveira Suruagy-Motta
LSLeonardo Dexheimer da Silva
Leonardo Dexheimer da Silva
KSKarlos Daniell Araújo dos Santos
Karlos Daniell Araújo dos Santos
ACAdriano Caixeta
Adriano Caixeta
Background Contrast-associated acute kidney injury (CA-AKI) results in increased morbidity and mortality, prolonged hospitalization, and worse clinical outcomes. Prior studies have shown that limiting contrast volume (CV) to less than 3 times the estimated glomerular filtration rate (eGFR) implies a lower risk of CA-AKI, and both efficacy and superior outcomes are associated with ultra-low contrast (ULC) volume coronary procedures (total CV ≤ eGFR). Objectives This systematic review and meta-analysis aimed to compare clinical outcomes of ULC versus conventional percutaneous coronary intervention (PCI) in patients with chronic kidney disease. Methods The search was conducted in the databases PubMed/MEDLINE, Cochrane, Embase, Scopus, and Web of Science, including all studies reporting clinical outcomes of ULC PCI. The primary efficacy endpoint was the incidence of CA-AKI, and secondary endpoints were need for dialysis, all-cause mortality, and major adverse cardiovascular events (MACE), defined as the composite endpoint of all-cause mortality, non-fatal myocardial infarction, and clinically driven target lesion revascularization. Results Six studies met the inclusion criteria and were included in the final analysis, encompassing a total of 274,102 patients. ULC PCI was associated with a statistically significant reduction of CA-AKI (risk ratio=0.27; 95% CI=0.13–0.56; p=0.0004). In turn, ULC PCI did not result in statistically significant reduction of need for dialysis (risk ratio=0.33; 95% CI=0.06–1.72; p=0.186), all-cause mortality (risk ratio=0.48; 95% CI=0.17–1.39; p=0.18), and MACE (risk ratio=0.52; 95% CI= 0.21–1.30; p=0.16). Conclusions ULC, as compared to conventional PCI, in patients with chronic kidney disease, was found to be safe, feasible, and associated with a statistically significant reduction of CA-AKI. Further, larger, well-powered, randomized, and controlled trials are warranted in order to reassure these findings.

23 September 2025 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Closed access
RGRoberta Andreucci Pereira Gomes
Roberta Andreucci Pereira Gomes
RMRicardo Fonseca Oliveira Suruagy Motta
Ricardo Fonseca Oliveira Suruagy Motta
EFEvandro Martins Filho
Evandro Martins Filho
LCLidia Cheidde
Lidia Cheidde
KSKarlos Daniell Araújo Dos Santos
Karlos Daniell Araújo Dos Santos
KMKalgi Modi
Kalgi Modi